Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ChemoCentryxKaruna TherapeuticsEpizymeZogenixArQule
SymbolNASDAQ:CCXINASDAQ:KRTXNASDAQ:EPZMNASDAQ:ZGNXNASDAQ:ARQL
Price Information
Current Price$48.87$96.82$24.88$30.16$20.00
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$50.00$110.13$27.14$59.20$17.50
% Upside from Price Target2.31% upside13.74% upside9.10% upside96.29% upside-12.50% downside
Trade Information
Market Cap$2.88 billion$2.33 billion$2.32 billion$1.37 billion$2.42 billion
Beta2.4N/A2.762.012.49
Average Volume455,193321,845868,8141,431,9545,269,080
Sales & Book Value
Annual Revenue$42.88 millionN/A$21.70 million$9.82 million$25.76 million
Price / Sales66.16N/A104.42135.9393.85
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.29 per shareN/A$2.94 per share$12.46 per share$0.72 per share
Price / Book168.52N/A8.462.4227.78
Profitability
Net Income$-37,970,000.00N/A$-123,630,000.00$-123,910,000.00$-15,480,000.00
EPS($0.76)N/A($1.72)($3.23)($0.16)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-143.30%N/A-468.53%N/A-805.61%
Return on Equity (ROE)-88.76%N/A-49.38%-31.44%-33.10%
Return on Assets (ROA)-23.42%N/A-39.27%-23.59%-26.87%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.32%N/A0.03%0.04%0.08%
Current Ratio3.12%106.93%10.90%3.00%8.27%
Quick Ratio3.12%106.93%10.90%3.00%8.27%
Ownership Information
Institutional Ownership Percentage66.24%48.74%85.86%N/A74.63%
Insider Ownership Percentage12.20%N/A16.60%4.40%13.80%
Miscellaneous
Employees76131249036
Shares Outstanding58.05 million23.41 million91.07 million44.26 million120.87 million
Next Earnings Date3/9/2020 (Estimated)2/27/2020 (Estimated)2/24/2020 (Confirmed)2/27/2020 (Estimated)3/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel